Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01451255 · ClinicalTrials.gov registry record
Early Detection of Pulmonary Arterial Hypertension Using Cardiac Magnetic Resonance Imaging
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 90
- Enrollment target
NCT01451255: Completed study, sponsored by Mayo Clinic.
NCT01451255 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 90 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01451255 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 90 participants
- Enrollment target
Study Summary
Cardiac magnetic resonance imaging has emerged as a potential valuable test for the early detection of Pulmonary Arterial Hypertension. A number of reports have provided some preliminary evidence that Pulmonary Artery (PA) stiffness may be accurately detected by imaging of the pulmonary artery in order to measure PA stiffness. In addition, cardiac MRI could play provide early and effective treatment for Pulmonary Arterial Hypertension (PAH).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2011-08 |
| Est. Completion | 2014-06 |
What the finished NCT01451255 record still lists
NCT01451255 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 90 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01451255 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01451255 about?
NCT01451255 is a clinical study titled "Early Detection of Pulmonary Arterial Hypertension Using Cardiac Magnetic Resonance Imaging". Cardiac magnetic resonance imaging has emerged as a potential valuable test for the early detection of Pulmonary Arterial Hypertension. A number of reports have provided some preliminary evidence that Pulmonary Artery (PA) stiffness may be accurately detected by imaging of the pulmonary artery in or...
What is the current status of trial NCT01451255?
This trial is currently completed. The enrollment target is 90 participants. The study started on 2011-08. Estimated completion is 2014-06.
Who is sponsoring clinical trial NCT01451255?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02521311 · 90 participants · Phase 2
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- NCT02939573 · 90 participants · Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
- NCT03128879 · 90 participants · Phase 2
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
- NCT03184038 · 90 participants · NA
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia